The FDA has approved Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic triple‑negative breast ...

Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...

Izalontamab brengitecan more than doubled PFS compared with chemotherapy ...

The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with unresectable or metastatic triple-negative breast cancer who are not candidates for ...

A first-in-class bispecific antibody-drug conjugate that Bristol Myers Squibb paid $800 million for has shown strong phase 3 ...

The Food and Drug Administration (FDA) on May 22, 2026, approved Datroway (datopotamab deruxtecan-dlnk) for adult patients ...

Hearing the words “triple-negative breast cancer” (TNBC) can be overwhelming. It’s a diagnosis that sounds heavy — not just because breast cancer itself is frightening, but because this particular ...

Strides in cancer research are happening in Dallas. Most recently, breast cancer doctors say they may have found a new way to fight one of the most devastating subtypes of cancer. UT Southwestern ...

Although it is commonly known that breast cancer is classified into different stages, many may be unaware that there are also different types of breast cancer. One rare form of the disease is ...

Members of a local homeschool group have banded together to help one of their own through a difficult diagnosis. Emma Truman, 30, is battling stage four triple-negative breast cancer, an ...

Massachusetts Department of Public Health is carrying out an environmental assessment at Uxbridge High School property to ...

Breast cancer deaths, once concentrated mostly among older women, are now claiming younger women more often, researchers ...